San Diego, CA, United States of America

Ta-Hsiang Chao

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 6.4

ph-index = 3

Forward Citations = 64(Granted Patents)


Company Filing History:


Years Active: 2007-2013

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovations of Ta-Hsiang Chao

Introduction

Ta-Hsiang Chao is an esteemed inventor based in San Diego, California, known for his significant contributions to the field of pharmaceuticals. With a total of seven patents to his name, Chao has focused on developing innovative compounds aimed at treating various diseases.

Latest Patents

His recent patents revolve around proteasome inhibitors, which disclose compounds of Formula (I) that include a sulfonate ester, ester, or ether group. These compounds can be formulated into pharmaceutical compositions for the treatment and amelioration of diseases such as cancer, microbial infections, and inflammation. The repetition of these innovative compounds underscores Chao's dedication to advancing therapeutic options in medicine.

Career Highlights

Throughout his career, Ta-Hsiang Chao has worked with notable companies, including Nereus Pharmaceuticals, Inc. and the University of California. His collaboration with these organizations has been pivotal in the advancement of his research and the development of groundbreaking inventions.

Collaborations

Chao has collaborated with esteemed colleagues, including Barbara Christine Potts and Venkat Rami Reddy Macherla. These partnerships highlight the collaborative nature of scientific research, allowing for the merging of ideas and expertise to foster innovation in the pharmaceutical field.

Conclusion

Ta-Hsiang Chao continues to make remarkable strides in the arena of pharmaceuticals through his inventive work on proteasome inhibitors. His contributions not only demonstrate his expertise as an inventor but also hold promise for potential advancements in treating critical medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…